Differential gene expression analysis of subcutaneous fat, fascia, and skin overlying a dupuytren's disease nodule in comparison to control tissue

Hand

Volumn 4, Issue 3, 2009, Pages 294-301

  Shih, Barbara ^a   Brown, Jason J ^a   Armstrong, Daniel J ^c   Lindau, Tommy ^c   Bayat, Ardeshir ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c DERBYSHIRE ROYAL INFIRMARY   (United Kingdom)

Author keywords

Dupuytren's contracture; Dupuytren's disease; Gene expression; Recurrence; Skin overlying nodule; Subcutaneous fat; Transcriptomics; Transverse palmar fascia

Indexed keywords

EID: 68949090460     PISSN: 15589447     EISSN: 15589455     Source Type: Journal    
DOI: 10.1007/s11552-009-9164-0     Document Type: Article

References (47)

1. Bayat A, McGrouther DA. Management of Dupuytren's disease - Clear advice for an elusive condition. Ann R Coll Surg Engl 2006;88:3-8.
2. Bergenudd H, Lindgarde F, Nilsson BE. Prevalence of dupuytren's contracture and its correlation with degenerative changes of the hands and feet and with criteria of general health. J Hand Surg 1993;18 B:254-7.
3. Burke FD, Proud G, Lawson IJ, et al. An assessment of the effects of exposure to vibration, smoking, alcohol and diabetes on the prevalence of dupuytren's disease in 97,537 miners. J Hand Surg: European Volume 2007;32:400-6.
4. Carl-McGrath S, Lendeckel U, Ebert M, et al. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer. Int J Oncol 2005;26:17-24.
5. Collard F, Vertommen D, Fortpied J, et al. Identification of 3-deoxyglucosone dehydrogenase as aldehyde dehydrogenase 1A1 (retinaldehyde dehydrogenase 1). Biochimie 2007;89:369-73.
6. Degreef I, Steeno P, De Smet L. A survey of clinical manifestations and risk factors in women with Dupuytren's disease. Acta Orthop Belg 2008;74:456-60.
7. Dyczynska E, Syta E, Sun D, et al. Breast cancer-associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein. Int J Cancer 2008;122:2634-40.
8. Flint M. The genesis of the palmar lesion. In: Mcfarlane RM, Mcgrouther DA, Flint MH, editors. Dupuytren's disease: Biology and treatment. New York: Churchill Livingstone; 1990. p. 140-5.
9. Frohlich C, Albrechtsen R, Dyrskjøt L, et al. Molecular profiling of ADAM12 in human bladder cancer. Clin Cancer Res 2006;12:7359-68.
10. Gabbiani G, Majno G. Dupuytren's contracture: Fibroblast contraction? An ultrastructural study. Am J Pathol 1972;66:131-46.
11. Gonzalez-Cadavid NF, Rajfer J. Mechanisms of disease: New insights into the cellular and molecular pathology of Peyronie's disease. Nat Clin Pract Urol 2005;2:291-7.
12. Gurtner GC, Werner S, Barrandon Y, et al. Wound repair and regeneration. Nature 2008;453:314-21.
13. Hall PN, Fitzgerald A, Sterne GD, et al. Skin replacement in Dupuytren's disease. J Hand Surg (Edinburgh, Lothian) 1997;22:193-7.
14. Hindocha S, Stanley JK, Watson JS, et al. Revised tubiana's staging system for assessment of disease severity in dupuytren's disease - Preliminary clinical findings. Hand 2008;3:80-6.
15. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007;127:526-37.
16. Hnanicek J, Cimburova M, Putova I, et al. Lack of association of iron metabolism and Dupuytren's disease. J Eur Acad Dermatol Venereol 2008;22:476-80.
17. Houweling AC, Dildrop R, Peters T, et al. Gene and cluster-specific expression of the Iroquois family members during mouse development. Mech Dev 2001;107:169-74.
18. Hu FZ, Nystrom A, Ahmed A, et al. Mapping of an autosomal dominant gene for Dupuytren's contracture to chromosome 16q in a Swedish family. Clin Genet 2005;68:424-9.
19. Iba K, Albrechtsen R, Gilpin BJ, et al. Cysteine-rich domain of human ADAM 12 (meltrin α) supports tumor cell adhesion. Am J Pathol 1999;154:1489-501.
20. Jelski W, Szmitkowski M. Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) in the cancer diseases. Clin Chim Acta 2008;395:1-5.
21. Kodama T, Ikeda E, Okada A, et al. ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor. Am J Pathol 2004;165:1743-53.
22. Kveiborg M, Frohlich C, Albrechtsen R, et al. A role for ADAM12 in breast tumor progression and stromal cell apoptosis. Cancer Res 2005;65:4754-61.
23. Le Pabic H, Bonnier D, Wewer UM, et al. ADAM12 in human liver cancers: TGF-β-regulated expression in stellate cells is associated with matrix remodeling. Hepatology 2003;37:1056-66.
24. Li Y, Huard J. Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 2002;161:895-907.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001;25:402-8.
26. Mackay DL, Tesar PJ, Liang LN, et al. Characterizing medullary and human mesenchymal stem cell-derived adipocytes. J Cell Physiol 2006;207:722-8.
27. Martini AK. The anatomical relationship between the skin and pathologically altered aponeurosis in Dupuytren's disease. Handchir Mikrochir Plast Chir 1985;17:134-8. (DIE ANATOMISCHEN BEZIEHUNGEN ZWISCHEN HAUT UND PATHOLOGISCH VERANDERTER APONEUROSE BEIM MORBUS DUPUYTHEN).
28. Martini AK, Puhl W. Micromorphological studies in Dupuytren's disease. Z Orthop Ihre Grenzgeb 1980;118:291-9.
29. Moyer KE, Banducci DR, Graham Iii WP, et al. Dupuytren's disease: physiologic changes in nodule and cord fibroblasts through aging in vitro. Plast Reconstr Surg 2002;110:187-93.
30. Myrthue A, Rademacher BL, Pittsenbarger J, et al. The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells. Clin Cancer Res 2008;14:3562-70. (An official journal of the American Association for Cancer Research).
31. Peduto L, Reuter VE, Sehara-Fujisawa A, et al. ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression. Oncogene 2006;25:5462-6.
32. Petrofsky JS, Prowse M, Lohman E. The influence of ageing and diabetes on skin and subcutaneous fat thickness in different regions of the body. J Appl Res 2008;8:55-61.
33. Rabinowitz JL, Ostermann Jr L, Bora FW, et al. Lipid composition and de novo lipid biosynthesis of human palmar fat in Dupuytren's disease. Lipids 1983;18:371-4.
34. Rea S, O'Sullivan ST. The polymerase chain reaction and its application to clinical plastic surgery. J Plas Rec Aesthet Surg 2006;59:113-21.
35. Rehman S, Salway F, Stanley JK, et al. Molecular phenotypic descriptors of Dupuytren's disease defined using informatics analysis of the transcriptome. J Hand Surg 2008;33:359-72.
36. Ross DC. Epidemiology of Dupuytren's disease. Hand Clin 1999;15:53-62.
37. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protocols 2008;3:1101-8.
38. Seifert O, Bayat A, Geffers R, et al. Identification of unique gene expression patterns within different lesional sites of keloids. Wound Repair Regen 2008;16:254-65.
39. Shih B, Wijeratne D, Armstrong DJ, et al. Identification of biomarkers in Dupuytren's disease by comparative analysis of fibroblasts versus tissue biopsies in disease-specific phenotypes. J Hand Surg 2009;34:124-36.
40. Tonkin MA, Lennon WP. Dermofasciectomy and proximal interphalangeal joint replacement in Dupuytren's disease. J Hand Surg (Edinburgh, Lothian) 1985;10:351-2.
41. Tonkin MA, Burke FD, Varian JPW. Dupuytren's contracture: A comparative study of fasciectomy and dermofasciectomy in one hundred patients. Br J Oral Maxillofac Surg 1984;9:156-62.
42. Valfrè Di Bonzo L, Ferrero I, Cravanzola C, et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: Engraftment and hepatocyte differentiation versus profibrogenic potential. Gut 2008;57:223-31.
43. VanGuilder HD, Vrana KE, Freeman WM. Twenty-five years of quantitative PCR for gene expression analysis. BioTechniques 2008;44:619-26.
44. Van Tuyl M, Liu J, Groenman F, et al. Iroquois genes influence proximo-distal morphogenesis during rat lung development. Am J Physiol, Lung Cell Mol Physiol 2006;290(4):L777-89.
45. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev, Cancer 2008;8:755-68.
46. Warren RF. The pathology of Dupuytren's contracture. Br J Plast Surg 1953;6:224-30.
47. Wu X, Zvonic S, Floyd ZE, et al. Induction of circadian gene expression in human subcutaneous adipose-derived stem cells. Obesity 2007;15:2560-70.